Invest A/s Lundbeckfond is 10% Owner at IO Biotech, Inc. (IOBT). They have made 6 open-market trades across 6 companies since 2014, most recently 2023-11-07.
CIK 0001591046
6 open-market purchases totalling $49.9M since 2014, never a sale. Across 5 scored buys the stock is up 30.7% at ninety days, and 22.3 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 80% | 40% | 60% |
| Avg Move | +0.8% | -6.7% | +30.7% |
| Alpha | -1.6% | -11.5% | +22.3% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LXEO | BUY | 2023-11-07 | 2023-11-09 | $11.00 | $2.5M | +5.4% | -3.4% | +62.7% |
| IOBT | BUY | 2021-11-09 | 2021-11-12 | $14.00 | $30.0M | -40.1% | -17.7% | -31.7% |
| IMRA | BUY | 2020-03-16 | 2020-03-16 | $16.00 | $3.0M | +3.0% | +0.4% | +150.4% |
| TRVI | BUY | 2019-05-09 | 2019-05-13 | $10.00 | $3.8M | +12.5% | +3.2% | -36.4% |
| SCPH | BUY | 2017-11-21 | 2017-11-21 | $14.00 | $9.2M | +23.5% | -15.8% | +8.3% |
| CLDN | BUY | 2014-02-04 | 2014-02-06 | $8.00 | $1.5M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.